Cited by 218Stroke Rehabilitation and RecoveryDementia and Cognitive Impairment ResearchNeurological Disorders and Treatments

Escitalopram and Enhancement of Cognitive Recovery Following Stroke

Open access
Jorge, Ricardo E., Acion, Laura, Moser, David, Adams, Harold P., Robinson, Robert G.·2010·Archives of General Psychiatry

Abstract

CONTEXT: Adjunctive restorative therapies administered during the first few months after stroke, the period with the greatest degree of spontaneous recovery, reduce the number of stroke patients with significant disability. OBJECTIVE: To examine the effect of escitalopram on cognitive outcome. We hypothesized that patients who received escitalopram would show improved performance in neuropsychological tests assessing memory and executive functions than patients who received placebo or underwent Problem Solving Therapy. DESIGN: Randomized trial. SETTING: Stroke center. PARTICIPANTS: One hundred twenty-nine patients were treated within 3 months following stroke. The 12-month trial included 3 arms: a double-blind placebo-controlled comparison of escitalopram (n = 43) with placebo (n = 45), and a nonblinded arm of Problem Solving Therapy (n = 41). OUTCOME MEASURES: Change in scores from baseline to the end of treatment for the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and Trail-Making, Controlled Oral Word Association, Wechsler Adult Intelligence Scale-III Similarities, and Stroop tests. RESULTS: We found a difference among the 3 treatment groups in change in RBANS total score (P < .01) and RBANS delayed memory score (P < .01). After adjusting for possible confounders, there was a significant effect of escitalopram treatment on the change in RBANS total score (P < .01, adjusted mean change in score: escitalopram group, 10.0; nonescitalopram group, 3.1) and the change in RBANS delayed memory score (P < .01, adjusted mean change in score: escitalopram group, 11.3; nonescitalopram group, 2.5). We did not observe treatment effects in other neuropsychological measures. CONCLUSIONS: When compared with patients who received placebo or underwent Problem Solving Therapy, stroke patients who received escitalopram showed improvement in global cognitive functioning, specifically in verbal and visual memory functions. This beneficial effect of escitalopram was independent of its effect on depression. The utility of antidepressants in the process of poststroke recovery should be further investigated. Trial Registration clinicaltrials.gov Identifier: NCT00071643.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/archgenpsychiatry.2009.185

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HDAC inhibition increases expression of plasticity-related factors and promotes ocular dominance plasticity in the visual cortex.

    “HDAC inhibition increases the expression of plasticity-related factors and promotes OD plasticity in the visual cortex194,205,206.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jorge, R. E., Acion, L., Moser, D., Adams, H. P., & Robinson, R. G.
Affiliations
University of Iowa (US)
Venue
Archives of General Psychiatry
Published
2010-02-01
Volume
67
Issue
2
Pages
187
ISSN
0003-990X (ISSN-L)
OpenAlex
W2140658948
Cited by
218
References
90
Citations by year
2026: 5 · 2025: 9 · 2024: 7 · 2023: 9 · 2022: 14 · 2021: 20 · 2020: 10 · 2019: 13 · 2018: 12 · 2017: 15 · 2016: 9 · 2015: 11 · 2014: 16 · 2013: 20 · 2012: 18
FWCI
22.63
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Archives of General Psychiatry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Pfizer
  • AstraZeneca
  • Sanofi
  • National Institute of Mental Health (R01-MH65134, R01MH065134)
Topics
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
Keywords
escitalopram, stroke, cognitive recovery, antidepressants, memory, executive function, problem-solving therapy, stroke recovery, depression, neuropsychological outcomes
MeSH terms
Aged, Cognition Disorders, Female, Humans, Male, Neuropsychological Tests, Problem Solving, Citalopram, Selective Serotonin Reuptake Inhibitors, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review